Literature DB >> 16214652

Priapism in sickle cell disease.

Zora R Rogers1.   

Abstract

Priapism, an unwanted painful erection of the penis, is a little discussed but common complication of sickle cell disease. What is known about the prevalence of priapism, efficacy of management approaches, and outcome is drawn primarily from retrospective and single-center reports. Priapism occurs in two patterns: prolonged and stuttering (ie, recurrent brief episodes that resolve spontaneously). If priapism persists for 4 hours or more without detumescence, the patient is at risk for irreversible ischemic penile injury, which may terminate in fibrosis and impotence. Large multicenter studies examining the epidemiology and current treatments and well-organized trials of novel therapies are urgently needed for patients who have sickle cell disease and priapism.

Entities:  

Mesh:

Year:  2005        PMID: 16214652     DOI: 10.1016/j.hoc.2005.08.003

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  13 in total

Review 1.  Priapism in sickle-cell disease: a hematologist's perspective.

Authors:  Gregory J Kato
Journal:  J Sex Med       Date:  2011-05-06       Impact factor: 3.802

2.  Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease.

Authors:  Ramiro Juncos; Luis Juncos; Robert P Hebbel; Gregory M Vercellotti; Zvonimir S Katusic; Karl A Nath
Journal:  J Cardiovasc Pharmacol       Date:  2011-02       Impact factor: 3.105

3.  Sickle cell disease: an opportunity for palliative care across the life span.

Authors:  Diana J Wilkie; Bonnye Johnson; A Kyle Mack; Richard Labotka; Robert E Molokie
Journal:  Nurs Clin North Am       Date:  2010-09       Impact factor: 1.208

4.  Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion.

Authors:  Mohammad S Ebraheem; Madeleine Verhovsek
Journal:  Blood Adv       Date:  2021-12-14

Review 5.  Sickle cell disease in childhood: from newborn screening through transition to adult medical care.

Authors:  Charles T Quinn
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

Review 6.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

7.  [Segmental testicular infarction in sickle cell anemia].

Authors:  F E Mueller
Journal:  Urologe A       Date:  2014-05       Impact factor: 0.639

8.  Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia.

Authors:  Mário Angelo Claudino; Kleber Yotsumoto Fertrin
Journal:  Anemia       Date:  2012-06-13

Review 9.  A biopsychosocial model for the management of patients with sickle-cell disease transitioning to adult medical care.

Authors:  Lori E Crosby; Charles T Quinn; Karen A Kalinyak
Journal:  Adv Ther       Date:  2015-04-02       Impact factor: 3.845

10.  Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility endpoints.

Authors:  Kea M Jones; Mohammad S Niaz; Cynthia M Brooks; Shannon I Roberson; Maria P Aguinaga; Edward R Hills; Valerie Montgomery Rice; Phillip Bourne; Donald Bruce; Anthony E Archibong
Journal:  Int J Environ Res Public Health       Date:  2009-03-16       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.